 Wilms Tumor
"Wilms Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN.
| Descriptor ID |
D009396
|
| MeSH Number(s) |
C04.557.435.595 C04.588.945.947.535.585 C04.700.635 C12.758.820.750.585 C12.777.419.473.585 C13.351.937.820.535.585 C13.351.968.419.473.585 C16.320.700.642
|
| Concept/Terms |
Wilms Tumor- Wilms Tumor
- Tumor, Wilms
- Wilms' Tumor
- Tumor, Wilms'
- Wilm Tumor
- Wilm's Tumor
- Wilms Tumor 1
- Nephroblastoma
- Nephroblastomas
|
Below are MeSH descriptors whose meaning is more general than "Wilms Tumor".
Below are MeSH descriptors whose meaning is more specific than "Wilms Tumor".
This graph shows the total number of publications written about "Wilms Tumor" by people in this website by year, and whether "Wilms Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 | | 2001 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2009 | 1 | 0 | 1 | | 2011 | 3 | 0 | 3 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 1 | 3 | | 2014 | 2 | 0 | 2 | | 2015 | 1 | 1 | 2 | | 2016 | 0 | 2 | 2 | | 2017 | 4 | 2 | 6 | | 2018 | 4 | 0 | 4 | | 2019 | 9 | 1 | 10 | | 2020 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2022 | 4 | 0 | 4 | | 2023 | 6 | 0 | 6 | | 2024 | 4 | 0 | 4 | | 2025 | 10 | 1 | 11 | | 2026 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Wilms Tumor" by people in Profiles.
-
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer. 2026 Oct 01; 132(19):e70610.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
-
Murphy AJ, Santiago T, Cost NG. Wilms Tumor. Surg Oncol Clin N Am. 2026 10; 35(4):695-714.
-
Velasquez-Herrera T, Valverde P, Fuentes S, Peña A, Ortiz R, Calderon P, Montero M, Gattuso G, Blanco J, Arreola M, Fernandez-Pineda I, Metzger M, Luna-Fineman S, Wilimas J, Spreafico F. Second Generation of AHOPCA (Asociación de Hemato-Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatr Blood Cancer. 2026 Feb; 73(2):e32148.
-
Balis F, Green DM, Armstrong A, Aye J, Benedetti D, Brown B, Brown E, Cook S, Desai A, Dhillon J, Fair D, Geynisman DM, Hiniker S, Horst K, Jasty-Rao R, Just M, Kieran K, Lin C, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Pinto N, Ranalli M, Rhee D, Rokitka D, Walz A, Wickiser J, Yoon J, Zapala M, Montgomery S, Sliker B. Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 08; 23(8):319-342.
-
Groisser A, Frantz A, Geller JI, Ortiz MV, Walterhouse D, Ranalli M, Woods-Swafford W, Schoettler P, Garrington T, Mullen EA, Ash S, Bardhan P, Balis F, Dome JS. Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatr Blood Cancer. 2025 Oct; 72(10):e31915.
-
Benedetti DJ, Cost NG, Ehrlich PF, Evageliou N, Fialkowski E, Parsons LN, Vallance KL, Renfro LA, Hong AL, Aldrink JH, Pater L, Paulino AC, Sandberg JK, Smith EA, Treece AL, Dome JS, Geller JI, Mullen EA. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. Nat Rev Urol. 2025 11; 22(11):775-788.
-
van Peer SE, Treger TD, Wegert J, Hol JA, Le Gall J, Jakkula EE, Kamihara J, Mullen EA, Graf N, Behjati S, Al-Saadi R, Duncan C, Schienda J, de Putter R, Brzezinski J, Verschuur A, Michaeli O, Ortiz MV, Herkert JC, Armstrong R, Waanders E, Kuiper RP, van den Heuvel-Eibrink MM, Gessler M, Jongmans MCJ. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants. Genet Med. 2025 Sep; 27(9):101478.
-
Campwala I, Schienda J, Murphy AJ, Hashimi B, Perry T, Cost N, Kamihara J, Mullen EA, Santiago T, Malek MM. Wilms Tumor in Children With AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series. Pediatr Blood Cancer. 2025 Aug; 72(8):e31798.
-
Pio L, Bruno T, Godzinski J, Ehrlich PF, Cost N, Davidoff AM, Irtan S, Pachl M, Abu-Zaid A, Abdelhafeez AH, Losty PD. Comparison of open and minimally invasive nephrectomy for Wilms tumor: a systematic review and meta-analysis from the International Society of Pediatric Surgical Oncology. Pediatr Surg Int. 2025 Apr 16; 41(1):117.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|